CPT code 0265U: Genome sequencing, rare heritable disorders2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Whole-genome and mitochondrial DNA sequencing identifies single-nucleotide and copy-number variants during evaluation of suspected rare constitutional or other heritable disorders.
Medicare pays $5,475.80 for 0265U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$5,475.80
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 0265U covers
This assay analyzes whole-genome and mitochondrial DNA for single-nucleotide and copy-number variants associated with rare constitutional or other heritable disorders. It is used when evaluating a suspected rare inherited condition. Accepted specimens include blood, frozen or formalin-fixed paraffin-embedded tissue, saliva, buccal swabs, and cell lines.
Report 0265U for the whole-genome and mitochondrial DNA analysis performed. Medicare pays the service through the CLFS at one national amount per code, applied across states and localities without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $5,475.80, unchanged from 2023 through 2025. Medicare payment for this code is through the CLFS rather than the physician fee schedule.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0265U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0265U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0265U: Medicare pays the test only from the CLFS.
0265U on the lab fee schedule since 2021
0265U · CLFS 2026 Q4 (current)
$5,475.80
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $5,475.80
21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.
0265U compared with similar tests
- 0260UGenome mappingStructural variant detection$1,263.53
- 0265U describes whole-genome and mitochondrial DNA analysis. 0260U describes rare-disease optical genome mapping.
- 0264UGenome mappingStructural variant detection$1,263.53
- 0265U describes whole-genome and mitochondrial DNA analysis. 0264U describes rare-disease optical genome mapping.
- 0267UGenome testMapping plus sequencing$6,739.33
- 0265U describes whole-genome and mitochondrial DNA analysis. 0267U describes rare-disorder optical genome mapping and sequencing.
- 0266UTranscriptome profilingExpression and splicing changes$3,200.00
- 0266U describes gene-expression testing for unexplained constitutional or heritable disorders; 0265U analyzes whole-genome and mitochondrial DNA.
0265U billing questions
Which specimens can be submitted for this assay?
Specimens include blood, frozen or formalin-fixed paraffin-embedded tissue, saliva, buccal swabs, and cell lines.
What does the assay evaluate?
It analyzes whole-genome and mitochondrial DNA for single-nucleotide and copy-number variants in evaluations of rare constitutional or other heritable disorders.
How does 0265U differ from rare-disease optical genome-mapping codes?
0265U describes whole-genome and mitochondrial DNA analysis. Codes 0260U and 0264U describe rare-disease optical genome mapping, while 0267U describes optical genome mapping and sequencing.
Does Medicare pay for this service through the CLFS or physician fee schedule?
Medicare pays 0265U through the CLFS.
Does the CLFS payment vary by location or setting?
No. One national amount applies across states and localities, without geographic or office-versus-facility adjustment.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0265U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist